ViiV, Vertex Sue Over Mylan's Bid To Market Generic Lexiva
ViiV Healthcare Co. and Vertex Pharmaceuticals Inc. slapped Mylan Inc. with a patent infringement lawsuit in Delaware on Wednesday over Mylan's bid for U.S. regulatory approval to make and sell a...To view the full article, register now.
Already a subscriber? Click here to view full article